Eric Shi

600 citations
8 papers · 307 indexed · h-index 6

Impact in

    • Oral microbiology and periodontitis research
    • Oral Health Pathology and Treatment
    • Liver physiology and pathology

Papers in

Eric Shi

8 papers receiving 299 citations

Peers

Eric Shi
Comparison fields: 5 of 56
  • Periodontics 46
  • Hepatology 47
  • Rheumatology 65
  • Cancer Research 51
  • Oncology 73
Replace Hiroko Kitahara with:
Hiroko Kitahara Japan
Francisco Hermida‐Prado Spain
Yasuyuki Kaneta Japan
Gregory Miles United States
H Takeyama Japan
Yuniel Fernández‐Marrero Switzerland
Mingbo Cao China
Lihong Yin United States
Yanling Fan China
Eric Shi relative to Hiroko Kitahara Japan Hiroko Kitahara's profile →
Citations per field
00.5×10×15.7×
Hiroko Kitahara · 1×
Citations per year

Countries citing papers authored by Eric Shi

Since Specialization
Citations

This map shows the geographic impact of Eric Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Shi more than expected).

Fields of papers citing papers by Eric Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Shi. The network helps show where Eric Shi may publish in the future.

Co-authors

The 25 scholars most cited alongside Eric Shi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Eric Shi Line = papers co-authored together Eric Shi links everyone, so they are left out of the graph.

All Works

8 of 8 papers shown
#Work
1
Scatter factor stimulates tumor growth and tumor angiogenesis in human breast cancers in the mammary fat pads of nude mice.
199776
2 200565
3 200154
4 200154
5 199242
6 20097
7 20095
8 20094

About Eric Shi

Eric Shi is a scholar working on Periodontics, Pharmacy, Cancer Research, Oncology and Molecular Biology, having authored 8 papers that have together received 307 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (3 papers), Signaling Pathways in Disease (2 papers), Protease and Inhibitor Mechanisms (2 papers), Cancer Cells and Metastasis (2 papers), Oral and gingival health research (1 paper), TGF-β signaling in diseases (1 paper), Cancer, Hypoxia, and Metabolism (1 paper) and Rheumatoid Arthritis Research and Therapies (1 paper). The work is most often cited by research in Periodontics (46 citations), Hepatology (47 citations), Rheumatology (65 citations), Cancer Research (51 citations) and Oncology (73 citations). Eric Shi has collaborated with scholars based in United States. Frequent co-authors include Nungavaram S. Ramamurthy, Robert A. Greenwald, Cong Li, Anu Gupta, Jingwen Liu, Peter J. Polverini, Alexander Fuchs, Katrin Lamszus, Liang Jin and Yongsheng Ma. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, The Journal of Steroid Biochemistry and Molecular Biology, Oncogene and Journal of Periodontology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026